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A Necessary Evil
Kaitlyn Marsh
In the year 1990, 600,000 people were diagnosed with a chronic disorder of the brain—
one with no cure. It will last the span of their entire lives. People suffering from this disorder
will experience fidgeting, impulsivity, irritability, absent-mindedness, difficulty focusing, and
most likely depression. These people will also be told by their doctors they will experience
troubled relationships and not be likely to succeed at school or work. They will be prescribed
psychologically addictive drugs to help them focus and “fit in”. This disorder is not contagious;
however, twenty-three years later 3.5 million people now own the diagnosis of the same
disorder. This disorder is attention-deficit hyperactivity disorder (ADHD). The drastic increase in
diagnoses of ADHD is not a result of a raging epidemic or plague. It is in fact a product of the
Diagnostic Statistical Manual for Mental Illnesses (DSM). The DSM is a manual created by
clinical researchers in psychology to diagnose and treat mental illnesses. It has received praise,
as it serves a valuable purpose. However, mental health professionals should be aware of
corruption hiding behind the authoritative DSM when diagnosing and treating patients, to be
sure not to contribute to the overmedication of society.
Pre-World War II, those with any type of mental illness were ruled insane. According to
the article “DSM History,” it was not until the prevalence of PTSD in war veterans that mental
illness in America was taken seriously (pars. 9-11). The United States Army was the first to
develop a system of classification that would better incorporate outpatient care of veterans.
The United States Army and the Veteran’s Administration pushed for The World Health
Organization (WHO) to include a section for mental illness in the International Classification of
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Disease (IDC) Manual (par. 10). In 1952, this goal was accomplished. But instead of simply
adding a section on mental illnesses, a new manual was produced. This manual was published
as the first edition of the Diagnostic and Statistical Manual for Mental Illnesses. The DSM
contains descriptions and symptoms of mental illnesses to ensure proper diagnosis for all
patients. Over the years, acceptance and knowledge of mental illnesses has grown. As a result,
the DSM has evolved to stand the test of time, and is now in its fifth edition.
The latest edition of the DSM (DSM-5) was released in 2013. The DSM, published by the
American Psychiatric Association (APA), covers mental illnesses apparent in all ages. It is most
commonly dubbed “The Psychiatrist’s Bible” due to how much some clinicians rely on and
praise it. The manual is not theoretical; it strives to be fact- and research-based. It lists
characteristics and descriptions of symptoms for any particular disorder. For example, Deborah
R. Glasofer, professor of clinical psychology, states that the DSM describes Generalized Anxiety
Disorder (GAD) as worrying excessively about a variety of things for at least or longer than six
months, spending the majority of waking hours worrying, and seeking reassurance from others
(par. 2). GAD is also classified by autonomic symptoms. To be diagnosed with GAD, a person
must meet at least three out of six of the physical symptoms, such as restlessness, fatigue
impaired concentration, irritability, increased muscle aches, or difficulty sleeping (par. 5).
Characterizing a mental illness is helpful to mental health professionals to ensure that everyone
is on the same page. Since mental illnesses can present themselves in different ways with
varying symptoms, a written account makes it easy to assess patients. The DSM also provides
statistical evidence as to what gender is most commonly affected, at what age the disease most
commonly presents itself, and the effects of treatment (Cherry and Gans, par. 2). The DSM is a
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living document, changing over time. The DSM has gone through five significant revisions
throughout its short lifespan. That it evolves to meet the needs of society is one reason why the
DSM has proven to be successful. In the first and second editions of the DSM, homosexuality
was an illness that could be diagnosed and treated. Jack Drescher, a psychoanalyst best known
for his studies in sexual orientation and gender identity, explains that the previous diagnosis of
homosexuality was wildly outdated. Drescher takes the words of Karl Heinrich Ulrichs, a man
who might be considered an early gay-rights activist who criticized German laws criminalizing
same-sex relations. Ulrichs describes a woman who is a lesbian as “a man’s spirit trapped in the
body of a woman” (par. 12). Drescher explains that back in Ulrichs’ time, this is what the people
would have believed. Anyone who was gay was pathologized and deemed mentally ill. Today,
homosexuality is generally accepted among psychologists, not looked at as an illness. The early
versions of the DSM reflect this. In 1973, the APA removed the diagnosis of homosexuality. This
was a result of a shift in societal beliefs (par. 1-2). Society was becoming more accepting of
homosexuality, and the DSM changed to fit the mold of society.
The DSM is essential in the field of psychology. The 947 pages of the manual give
authority to the realm of mental health. Psychology and mental health have had a rough fight
to become accepted in America. People who were mentally ill in the late 1800s to early 1900s
were treated poorly. According to the article “A Brief History of Mental Illness and the U.S.
Mental Health Care System,” the mentally ill were admitted into state hospitals and faced poor
living conditions and human rights violations (par. 4). This changed for the better when activist
Dorothea Dix pushed for the creation of the first generation of mental asylums. Even presentday, specific mental illnesses such as depression, dissociative identity disorder, and more still
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face skepticism and have to prove they are “real”. In the article “On the Medicalization of Our
Culture,” neuroscientist Steven E. Hyman says that the DSM is necessary because it gives
psychologists the same authority as other doctors, such as cardiologists (par. 19). Hyman
provides an example of the historically contrasting ways the healthcare system treats
schizophrenia and Parkinson’s disease. Parkinson’s disease has always been treated as having
more legitimacy. However, both diseases, at the very simplest levels, are dopamine issues.
Without the publication of the DSM, disorders such as schizophrenia would be perceived as
fake. The research behind the DSM gives mental illnesses credibility in America.
The DSM’s intended use is to ensure accuracy of diagnoses across a wide span of
people. In fact, the manual is not only used in the United States, but worldwide. Standardizing
all mental illnesses into categories assures that all patients with a DSM diagnosis receive fair
treatment, regardless of social class, location, or ability to pay (Fritscher, par. 14). Assuring that
all clients are diagnosed upon the same criteria, regardless of their background, promotes fair
treatment in the mental health field—so that a client who is economically disadvantaged
receives the same quality of treatment as another who is able to pay for treatment. Not only
does the DSM protect patients; it also protects mental health professionals who can us the
diagnostic checklist within the pages of the DSM as validation for the treatments they provide,
and this ensures some consistency around the world in studying and treating mental illnesses
(Fritscher, par. 14).
Another intended use of the DSM is to protect those with mental illnesses against unfair
treatment by law enforcement. Ralph Slovenko, one of America’s most renowned forensic
psychologists, quotes DSM-IV: “When used appropriately, diagnoses and diagnostic information
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can assist decision makers in their determinations. For example, when the presence of a mental
disorder is the predicate for a subsequent legal determination, the use of an established system
of diagnosis enhances the value and reliability of the determination” (Slovenko, par. 4). This
shows that a diagnosis from a reliable manual can be significant in a court of law. One example
of this is from a case of homicide in 2009. Brian Thomas and his wife went on vacation in
London, only for Thomas to strangle his wife to death in his sleep. Thomas murdered his wife
unconsciously, having no awareness of doing so, but he was faced with charges of murder.
However, his lifelong history of chronic sleep disorders presented him with a diagnosis of REM
Sleep Behavior Disorder (Morris, par. 4). REM Sleep Behavior Disorder is described as a person
acting out their dreams during REM sleep, a time when the body is supposed to be “paralyzed”.
Thomas did not have a diagnosis for REM sleep prior to his murder charges, but after spending
ten months in prison and going through numerous tests, it was confirmed that Thomas suffered
from REM Sleep Disorder. The jury ruled Thomas as not guilty, and he walked free (Morris, par.
9-14). Without the DSM, individuals like Thomas who were not conscious while committing
crimes would be sentenced to serve time in jail or prison. The DSM provides protection for
those diagnosed with a mental illness.
Although the intentions of the DSM seem good, it is still a controversial resource in not
only psychology, but in the realms of both medicine in general and insurance, as well. With
every update of the DSM, there is an overwhelming amount of controversy to follow.
Controversy surrounding the DSM-5 update is the idea of “false positives”. The term “false
positives” is used by some to describe, for instance, the increase in autism diagnoses in the past
decade. The Center for Disease Control and Prevention (CDC), estimates that one in 88 children
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in America has a diagnosis for autism (Grush, par. 7). In the article “The DSM-5 Is Here: What
the Controversial New Changes Mean for Mental Health Care,” Dr. Alexandar Kolevzon,
psychiatry professor at Mount Sinai Hospital, comments on how the changes in DSM-5 have
contributed to the increase in autism diagnoses. Kolevzon says, “DSM-5 groups all
subcategories of autism into a single category known as autism spectrum disorder (ASD)”
(Grush, par. 4). Kolevzon concludes that the grouping of categories includes children that have
been diagnosed with communication issues and patterned behavior, which explains the
increase in autism diagnoses. The changes that have been made in not only the autism section,
but also the sections pertaining to cannabis withdrawal, gambling addiction, and more are
highly controversial, and are continuing to be debated.
This is not the first or only time the DSM has been critiqued for being responsible for the
over medicalization of society. In the article “On the Medicalization of Our Culture”,
Christopher Lane, a professor of English with a focus in psychology, says, “The DSM criteria
grow longer and more commonplace with each edition of the diagnostic manual, and the
prevalence rates are revised upward so many times that more and more adults and children are
defined every year as mentally ill” (par. 15). Lane explains that as time goes on, more and more
diagnoses become apparent. Each time the DSM is updated, its expanded definitions result
more people falling under criteria for a diagnosis of a mental illness. Lane’s views on the DSM
shed light on the rise in autism diagnoses in America. Most likely, autism is not any more
prevalent than in the past; it is just being diagnosed more. This is a result of the criteria for
diagnosis widening and the acceptance of mental illness growing. The astonishing rise in rates
of ADHD diagnoses is one example of an area of concern. Keith Conners, the psychologist
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credited with first establishing the conditions for diagnosing ADHD, is not pleased with the
soaring rates of diagnosis. In a speech given to fellow ADHD specialists, Conners describes the
ADHD “epidemic” as “a natural disaster of dangerous proportions” (Schwarz, par. 3). Conners is
disappointed in the leeway the DSM has provided. The wide-ranging criteria of the DSM allow
for mental health professionals to diagnose a patient easily, thus expanding the medicalization
of society.
Another controversy surrounding the DSM is the idea that the DSM medicalizes
behaviors and moods that are not extreme. This controversy arose again soon after the DSM-5
was released. In the article “Normal Behavior, or Mental Illness?” former president of the
American Psychological Association, Frank Farley, gives his critique of the new updates:
...Anyone who overeats once a week for three weeks could have a “binge-eating
disorder.” Women not turned on sexually by their partners or particularly interested in
sex are candidates for “female sexual interest/arousal disorder.” Nail-biters join the
ranks of the obsessive-compulsive, alongside those with other “pathological grooming
habits” such as “hair-pulling” and “skin-picking” (Kingston, par. 4).
Farley explains that overeating, disinterest in sexual activity, and nail biting are common
behaviors that most humans experience from time to time. These common behaviors should
not be criteria for a diagnosis. Medicalizing behaviors and moods that are non-extreme is a
massive problem for not only the field of psychology, but humanity as a whole. In 2012, before
the DSM-5 was released, the most vocal critic, Allen Frances, hypothesized that diagnoses in
adult attention deficit disorder (AADD) will increase by a vast margin in the years to come.
Frances says this will lead to a “widespread misuse of stimulant drugs for performance
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enhancement and recreation” (par. 14). Hence, by prescribing stimulants to those who display
behaviors such as distraction, psychologists are contributing to the illegal market of diverted
prescription drugs (par. 14). In the year 2015, one-fifth of college students reported abusing
stimulants such as Adderall or Ritalin (Young, par. 3). Frances’s hypothesis was correct. College
students and young adults who wished to take stimulant drugs used to search far and wide for
a person to divert drugs to them. Nowadays, thanks to the DSM-5 medicalizing non-extreme
behaviors, stimulants and other prescription drugs are prevalent in society and extremely easy
to obtain. Obviously, the effects of medicalizing non-extreme moods and behaviors is handing
out prescription medicine like candy, which hurts not only those who are diagnosed, but society
as a whole.
Behind the scenes, pharmaceutical companies played a massive role in the writing and
production of the DSM. Ties between major pharmaceutical companies and the APA have been
apparent since the writing of the third revision of the DSM. Not only did Big Pharma fund
portions of research and of the publication costs of the DSM, Big Pharma has a history of paying
psychologists colossal amounts of money to push their agenda. In the journal article “The
Influence of Corporate and Political Interests on Models of Illness in the Evolution of the DSM,”
it is revealed that a psychologist was paid over $1.5 million by pharmaceutical companies to
research antipsychotic drug prescriptions in childhood disorders (par. 14). Authors Pilecki and
Clegg conclude that this is disturbing due to antipsychotic drugs possessing low efficacy rates as
compared to drugs with milder side effects. Pharmaceutical companies use the DSM to profit
off of insurance companies. When multiple “psychosocial interventions” are made available,
patients receive insurance coverage for treatment. With the insurance coverage, patients are
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prescribed drugs that make up the majority of the cost of treatment (par. 9-14). When a patient
is diagnosed with criteria listed in the DSM, insurance will then cover treatment, including the
often exorbitant costs of medications—medications that are often of questionable
effectiveness. This is why pharmaceutical companies have such great interest in what criteria
for diagnoses goes into the DSM.
In 1980, pharmaceutical company GlaxoSmithKline pushed for the psychiatric disorder
“social anxiety disorder” to be included in the DSM-III. GlaxoSmithKline then patented and
received approval from the FDA for the drug Paxil, which was marketed to treat anxiety
disorders. Sales for Paxil sky-rocketed into the billions (O’Connell, par. 8). Pharmaceutical
companies such as GlaxoSmithKline rake in their billion-dollar profits by paying smaller amounts
to members of the DSM panel or other influential psychologists. The members of the panel
then push Big Pharma’s agenda in the writing of the DSM. The criteria for diagnoses fit the
agenda of Big Pharma, which continually designs and markets new “medications” to treat these
mental illnesses. This process has been circulating since the production of DSM-III. In 2008, the
APA announced that all funding from pharmaceutical companies would be recorded. Only two
short months later, a study was conducted to determine if the APA was following code.
According to the article “Pharm Funded Psychiatrists and Conflicts of Interest,” the study
revealed that 18 out of 20 members assigned to writing clinical guidelines for three specific
mental disorders had been paid by pharmaceutical companies (pars. 1-3). This brought more
controversy and criticism into the production of DSM-5, as the paid members of the panel faced
no repercussions for receiving pay from pharmaceutical companies. One man who faced
congressional investigation for receiving pay is psychiatrist Dr. Charles B. Nemeroff. After
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signing a contract stating he would only receive up to $10,000 a year from GlaskoSmithKline,
Nemeroff was paid $3.9 million over the course of five years from the company (Harris 3, 16).
This is yet another example of how pharmaceutical companies can pay influential mental health
professionals to let their own agenda seep into the DSM, allowing pharmaceutical companies to
reap massive profits.
Another downfall of the DSM is that many mental health professionals misuse the
manual. Therapy and treatment costs can be overwhelmingly expensive for patients; most
people struggle with affording therapy, even with insurance coverage. Many mental health
professionals realize this is the reality of America’s healthcare system. In the article “How Much
Does Therapy Cost?” therapist Marla B. Cohen explains that therapy sessions on average cost
between $75-$150 a session (par. 7). To make costs more feasible for patients, psychologists
will sometimes diagnose a patient with a mental illness so insurance will cover treatment.
Michael Halpin, author of “The DSM and Professional Practice: Research, Clinical, and
Institutional Perspectives,” and recipient of multiple awards from Society for the Study of Social
Problems and the American Sociological Association, conducted an interview with an
anonymous psychologist. In the interview, Halpin asked questions pertaining to the DSM and its
billing purposes. When Halpin asked the anonymous psychologist what happens when she
assesses someone who is “actually healthy [or normal]”, the psychologist responded: “This is
going to sound awful, but a lot of times you can’t let a patient walk out of your office without a
diagnosis… without a diagnosis, insurance is not going to cover the visit” (Halpin 162-163). The
psychologist in Halpin’s interview went on to explain the patient was going through a rough
patch in her life and did not truly match any mental illness listed in the DSM. The patient simply
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needed an outlet to talk through her feelings, but insurance will not cover the therapy sessions
if there is no diagnosis. The psychologist diagnosed her patient with clinical depression so
insurance would cover therapy. The psychologist obviously had good intentions of helping her
patient through talk therapy. However, diagnosing patients with mental illnesses they do not
truly have is clearly abuse of the DSM.
I have been in the place of the psychologist’s patient. I went through somewhat of a
hard time during my senior year in high school and pursued talk therapy as a treatment. I
simply wanted someone to talk to about the hardships I was facing in life. I talked to a therapist
once a week for three weeks before I received a bill. Insurance would not cover therapy
because I did not have a diagnosis, and my bill was almost $800 for the three previous
appointments. However, I still wanted to pursue therapy somehow, so my mom contacted our
insurance company to find out how I could receive any coverage. I was sent to a psychologist
who diagnosed me with situational depression after only one office visit. I was prescribed
citalopram, an antidepressant. This experience was terrible. I believe I should not have been
prescribed the antidepressant. I preferred talk therapy, which I found helpful for getting
through the obstacles life threw at me, without taking medication that kept me up at night only
to think about the problems I was facing even more. Ultimately, I chose to end my sessions with
the psychologist and stop taking the medication. I have not been to therapy in over a year. I
eventually got through what I was facing on my own; however, I would still love to go to
therapy just to have an outlet, but I cannot afford it. I understand that diagnosing patients with
a mental illness becomes a way for psychologists and psychiatrists to decrease the costs to their
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patients, but using the DSM to diagnose patients with mental illnesses they do not have is not
correct. The practice of abusing the DSM leads to the over medicalization of society.
In the light of recent events, mental healthcare in America has received vocal criticism.
Event—including school shootings, suicide, opiate addiction, skyrocketing incarceration rates,
and more—have sparked the conversation about providing better mental healthcare treatment
options in America. However, there will be a long road to success. Major pharmaceutical
companies still reign behind the scenes, playing insurance companies and health professionals
as pawns, taking advantage of the DSM to make billions and billions of dollars. When mental
health professionals use the DSM to treat and diagnose patients, the intended goal is to create
a universal language of diagnosis so that all patients are evaluated with the same criteria. I
believe there is a way to use the DSM to diagnose patients without leaving it so vulnerable to
abuse. The first step is to break up Big Pharma. In the article “Big Pharma Has Broken Its Social
Contract: How to Restore Fairness In Drug Pricing,” Kenneth L. Davis, neurobiologist and CEO of
Mount Sinai Health System, says that the United States government should recognize the
monopolies certain pharmaceutical companies hold and break them to promote a beneficial
environment. Kenneth also proposes that members of the DSM panel should not be able to
accept monetary funds from pharmaceutical companies (par. 5). This will improve the quality of
the assessment criteria of the DSM; the criteria will not be biased or influenced based on
marketing or a bribe. The article “Achieving Access to Mental Health Care for School-Aged
Children in Rural Communities: A Literature Review,” written by Jacob Blackstock, an education
counselor, says that the best ways to improve mental health are to bring awareness, remove
stigmas, and provide resources in schools. This is based on research that schools are the
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primary environment where children display mental health problems (pg. 2, 4). If a child or
teenager has easy access to school guidance counselors, they have an inexpensive way of
promoting their mental health. A school guidance counselor is not licensed to diagnose mental
illnesses, so a student will receive no diagnosis from the DSM or medication. Another way
mental health care could be improved is to educate mental health professionals on the
limitations the DSM poses. Some mental health professionals rely on the DSM heavily for each
diagnosis they deliver, and some disregard the manual completely, only using it for insurance
billing purposes. By better educating each mental health professional on the potential risks of
mis-using the manual, the numbers of diagnoses would decrease.
The Psychiatrist’s Bible is a necessary evil. Without it, the lines of diagnosis would be
blurred and the field of psychology would possess less credibility for its diagnoses. However,
with it, diagnoses and prescription drugs are handed out like candy. The DSM provides a stage
for pharmaceutical companies to manipulate and control members of society as marionettes,
all for financial gain. Patients should educate themselves on the dangerous effects that a DSM
diagnosis is capable of inflicting. By prescribing vast amounts of medication to the general
population, mental health professionals are contributing to the overmedication of society,
which leads to dangerous paths. Mental health professionals must understand the corruption
and questionable motives that hide behind the DSM when diagnosing patients.
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